SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
SCHEDULE 13G
 
 
Under the Securities Exchange Act of 1934
 
(Amendment No.  )*
 

Alpha Healthcare Acquisition Corp. III
(Name of Issuer)
 

Class A common stock, par value $0.0001 per share
(Title of Class of Securities)
 

02073F104
(CUSIP Number)
 

December 31, 2021
(Date of event which requires filing of this statement)
 
 
Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
 
x Rule 13d-1(b)
¨ Rule 13d-1(c)
¨ Rule 13d-1(d)
 
(Page 1 of 8 Pages)

 

______________________________

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

CUSIP No. 02073F104

13G

 Page 2 of 8 Pages

 

1

NAMES OF REPORTING PERSONS

P. Schoenfeld Asset Management LP
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨
3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH		 5

SOLE VOTING POWER

- 0 -
6

SHARED VOTING POWER

1,485,000 shares of Class A Common Stock
7

SOLE DISPOSITIVE POWER

- 0 -
8

SHARED DISPOSITIVE POWER

1,485,000 shares of Class A Common Stock
9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,485,000 shares of Class A Common Stock
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.3%
12

TYPE OF REPORTING PERSON

IA, PN
         

 

CUSIP No. 02073F104

13G

 Page 3 of 8 Pages

 

1

NAMES OF REPORTING PERSONS

Peter M. Schoenfeld
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ¨
3 SEC USE ONLY
4

CITIZENSHIP OR PLACE OF ORGANIZATION

United States
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH		 5

SOLE VOTING POWER

- 0 -
6

SHARED VOTING POWER

1,485,000 shares of Class A Common Stock
7

SOLE DISPOSITIVE POWER

- 0 -
8

SHARED DISPOSITIVE POWER

1,485,000 shares of Class A Common Stock
9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

1,485,000 shares of Class A Common Stock
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

9.3%
12

TYPE OF REPORTING PERSON

IN
         

 

CUSIP No. 02073F104

13G

 Page 4 of 8 Pages

 

 

Item 1(a). NAME OF ISSUER.
   
  The name of the issuer is Alpha Healthcare Acquisition Corp. III (the "Company").

 

Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
   
  The Company's principal executive offices are located at 1177 Avenue of the Americas, 5th Floor, New York, NY 10036.

 

Item 2(a). NAME OF PERSON FILING:
   
  This statement is filed by:

 

  (i)

P. Schoenfeld Asset Management LP ("PSAM"), a Delaware limited partnership, and the investment adviser to certain funds and accounts (the "PSAM Funds"), with respect to the shares of Class A Common Stock (as defined in Item 2(d) below) directly held by the PSAM Funds; and

 
  (ii) Mr. Peter M. Schoenfeld ("Mr. Schoenfeld"), as the managing member of P. Schoenfeld Asset Management GP, LLC, a Delaware limited liability company that serves as the general partner of PSAM, with respect to the shares of Class A Common Stock directly held by the PSAM Funds.

 

  The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
   
  The filing of this statement should not be construed as an admission that any of the forgoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Class A Common Stock reported herein.  

 

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
   
  The address of the business office of each of the Reporting Persons is 1350 Avenue of the Americas, 21st Floor, New York, NY 10019.

 

Item 2(c). CITIZENSHIP:
   
  PSAM is a Delaware limited partnership.  Mr. Schoenfeld is a citizen of the United States.

 

Item 2(d). TITLE OF CLASS OF SECURITIES:
   
  Class A common stock, par value $0.0001 per share (the "Class A Common Stock").

 

 

CUSIP No. 02073F104

13G

 Page 5 of 8 Pages

 

Item 2(e). CUSIP NUMBER:
   
  02073F104

 

Item 3. IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

 

  (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
  (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
  (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
  (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
  (e) x Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
  (f) ¨

Employee benefit plan or endowment fund in accordance with

Rule 13d-1(b)(1)(ii)(F);

 
  (g) x

Parent holding company or control person in accordance with

Rule 13d-1(b)(1)(ii)(G);
  (h) ¨

Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

 
  (i) ¨

Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

 
  (j) ¨ Non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
  (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

 

 

If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please

specify the type of institution: ________________________

 

Item 4. OWNERSHIP.
   
  The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
   
  The percentages set forth herein are calculated based upon 15,907,985 shares of Class A Common Stock outstanding as of November 22, 2021, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2021, filed with the Securities and Exchange Commission on November 22, 2021.

 

Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
   
  Not applicable.

 

 

CUSIP No. 02073F104

13G

 Page 6 of 8 Pages

 

Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
   
  See Item 2.  The PSAM Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Class A Common Stock reported herein.  PSAM WorldArb Master Fund Ltd., a PSAM Fund, has the right to receive or the power to direct the receipt of dividends or the proceeds from the sale of more than 5% of the shares of Class A Common Stock.

 

Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
   
  Not applicable.

 

Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
   
  Not applicable.

 

Item 9. NOTICE OF DISSOLUTION OF GROUP.
   
  Not applicable.

 

Item 10. CERTIFICATION.

 

  Each of the Reporting Persons hereby makes the following certification:
   
  By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

CUSIP No. 02073F104

13G

 Page 7 of 8 Pages

 

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct.

DATED: February 13, 2023

 

P. SCHOENFELD ASSET MANAGEMENT LP  
   

By: P. Schoenfeld Asset Management GP LLC, its General Partner

 

  
By: /s/ Peter M. Schoenfeld  
Name:  Peter M. Schoenfeld  
Title:    Managing Member  
   
   
/s/ Peter M. Schoenfeld  
PETER M. SCHOENFELD  

 

 

 

CUSIP No. 02073F104

13G

 Page 8 of 8 Pages

 

EXHIBIT 1

JOINT ACQUISITION STATEMENT
PURSUANT TO RULE 13d-1(k)

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

DATED: February 13, 2023

 

P. SCHOENFELD ASSET MANAGEMENT LP  
   

By: P. Schoenfeld Asset Management GP LLC, its General Partner

 

  
By: /s/ Peter M. Schoenfeld  
Name:  Peter M. Schoenfeld  
Title:    Managing Member  
   
   
/s/ Peter M. Schoenfeld  
PETER M. SCHOENFELD  

 

Alpha Healthcare Acquisi... (NASDAQ:ALPAU)
Historical Stock Chart
From Aug 2023 to Sep 2023 Click Here for more Alpha Healthcare Acquisi... Charts.
Alpha Healthcare Acquisi... (NASDAQ:ALPAU)
Historical Stock Chart
From Sep 2022 to Sep 2023 Click Here for more Alpha Healthcare Acquisi... Charts.